GlaxoSmithKline Pharmaceuticals, launched the Herpes Zoster vaccine named Shingrix on Monday, is now focusing on adult vaccination in the country. GSK Pharmaceuticals MD Bhushan Akshikar talks to Sohini Das about the company’s India plans. Edited excerpts:
Why is it important to take the Shingles (Herpes Zoster) vaccine for adults?
Shingrix (Zoster vaccine recombinant) is for the prevention of shingles or what is also known as herpes zoster and also post-herpetic neuralgia in people aged 50 and above. It’s the world’s first non-live recombinant subunit vaccine administered through the intramuscular route in two doses.
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.
Subscribe To Insights
Key stories on business-standard.com are available to premium subscribers only.Already a BS Premium subscriber? Log in NOW
Or